Role of ING4 in human melanoma cell migration, invasion and patient survival

Carcinogenesis

Volumn 29, Issue 7, 2008, Pages 1373-1379

  Li, Jun ^a   Martinka, Magdalena ^a   Li, Gang ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; GELATINASE B; INHIBITOR OF GROWTH PROTEIN 4; RHO KINASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER SIZE; CANCER SURVIVAL; CELL MIGRATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DYSPLASTIC NEVUS; ENZYME INHIBITION; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MELANOMA; MELANOMA CELL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RISK FACTOR; STRESS FIBER; SURVIVAL TIME; ULCER;

CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL MOVEMENT; CELL TRANSFORMATION, NEOPLASTIC; DYSPLASTIC NEVUS SYNDROME; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MELANOMA; NEOPLASM INVASIVENESS; RHOA GTP-BINDING PROTEIN; STRESS FIBERS; SURVIVAL RATE; TRANSFECTION; TUMOR SUPPRESSOR PROTEINS;

EID: 49349105425     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgn086     Document Type: Article

References (42)

1. Jemal,A. et al. (2007) Cancer statistics, 2007. CA Cancer J. Clin.. 57, 43-66.
2. Soengas,M.S. et al. (2003) Apoptosis and melanoma chemoresistance. Oncogene, 22, 3138-3151.
3. Grossman,D. et al. (2001) Drug resistance in melanoma: Mechanisms, apoptosis, and new potential therapeutic targets. Cancer Metastasis Rev., 20, 3-11.
4. Ballo,M.T. et al.(2003) Radiation therapy for malignant melanoma. Surg. Clin. North Am., 83, 323-342.
5. Hersey,P. (2003) Adjuvant therapy for high-risk primary and resected metastatic melanoma. Intern. Med. J., 33, 33-43.
6. Miller,A.J. et al. (2006) Melanoma. N. Engl. J. Med., 355 51-65.
7. Gandini,S. et al. (2005) Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors. Eul: J. Cancer, 41, 2040-2059.
8. Gandini,S. et al. (2005) Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure. Eur J. Cancer, 41, 45-60.
9. Gandini,S. et al. (2005) Meta-analysis of risk factors for cutaneous melanoma: I. Common and a typical naevi. Eur. J. Cancer, 41, 28-44.
10. Wang,J. et al. (2006) The novel tumor suppressor p33ING2 enhances nucleotide excision repair via inducement of histone H4 acetylation and chromatin relaxation. Cancer Res., 66, 1906-1911.
11. Shiseki,M. et al. (2003) p29ING4 and p28ING5 bind to p53 and p300, and enhance p53 activity. Cancer Res., 63, 2373-2378.
12. Garkavtsev,I. el al. (2004) The candidate tumour suppressor protein ING4 regulates brain turnout growth and angiogenesis. Nature 428, 328-332.
13. Ozer,A. et al. (2005) The candidate tumor suppressor ING4 represses activation of the hypoxia inducible factor (HIF). Proc. Natl Acad. Sci. USA, 102, 7481-7486.
14. Dai,D.L. et al. (2005), Prognostic significance of activated Akt expression in melanoma: A clinicopathologic study of 292 cases. J. Clin. Oncol., 23, 1473-1482.
15. Remmele,W. et al. (1987) Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue. Pathologe, 8, 138-140.
16. Li,G. et al. (1998) Chemotherapy-induced apoptosis in melanoma cells is p53 dependent. Melanoma Res., 8, 17-23.
17. Wang,Y. et al. (2006) ING3 promotes UV-induced apoptosis via Fas/ caspase-8 pathway in melanoma cells. J. Biol. Chem., 281, 11887-11893.
18. Chin,M.Y et al. (2005) The novel tumor suppressor p33ING2 enhances UVB-induced apoptosis in human melanoma cells. Exp. Cell Res., 304, 531-543.
19. Wong,R.P. et al. (2007) The role of integrin-linked kinase in melanoma cell migration, invasion, and tumor growth. Mol. Cancer Ther 6, 1692-1700.
20. Unoki,M. et al. (2006) Novel splice variants of ING4 and their possible roles in the regulation of cell growth and motility. J. Biol. Chem., 281, 34677-34686.
21. Campos, E.I. et al. (2004) Mutations of the ING1 tumor suppressor gene detected in human melanoma abrogate nucleotide excision repair. Int. J. Oncol., 25, 73-80.
22. Nouman,G.S. et al. (2002) Nuclear to cytoplasmic compartment shift of the p33ING1b tumour suppressor protein is associated with malignancy in melanocytic lesions. Histopathology, 40, 360-366.
23. Wang,Y. et al. (2007) Prognostic significance of nuclear ING3 expression in human cutaneous melanoma. Clin. Cancer Res., 13 4111-4116.
24. Lu,F. et al. (2006) Nuclear ING2 expression is reduced in human cutaneous melanomas. Br. J. Cancer, 95, 80-86.
25. Cheung,K.J.Jr., et al. (2001) The tumor suppressor candidate p33(ING1) mediates repair of UV-damaged DNA. Cancer Res., 61 4974-4977.
26. Wang,Y. et al. (2006) Leucine zipper-like domain is required for tumor suppressor ING2-mediated nucleotide excision repair and apoptosis. FEBS Lett., 580, 3787-3793.
27. Cheung,K.J.Jr., et al. (2002) p33(ING1) enhances UVB-induced apoptosis in melanoma cells. Exp. Cell Res., 279, 291-298.
28. Gunduz,M. et al. (2005) Frequent deletion and down-regulation of ING4, a candidate tumor suppressor gene at 12p13, in head and neck squamous cell carcinomas. Gene, 356, 109-117.
29. Hassler,M. et al. (2006) Diversity of cytogenetic and pathohistologic profiles in glioblastoma. Cancer Genet. Cytogenet. 166, 46-55.
30. Kim,S. et al. (2004) A screen for genes that suppress loss of contact inhibition: Identification of ING4 as a candidate tumor suppressor gene in human cancer. Proc. Natl Acad. Sci. USA, 101 16251-16256.
31. Michaloglou,C. et al. (2005) BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature, 436, 720-724.
32. Chen,Z. et al. (2005) Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature, 436, 725-730.
33. Braig,M. et al. (2006) Oncogene-induced senescence: Putting the brakes on tumor development. Cancer Res., 66, 2881-2884.
34. Bernard,D. et al. (2004) Involvement of Rel/nuclear factor-kappaB transcription factors in keratinocyte senescence. Cancer Res., 64, 472-481.
35. Shen,J.C. et al. (2007) Inhibitor of growth 4 suppresses cell spreading and cell migration by interacting with a novel binding partner, liprin alpha1. Cancer Res., 67, 2552-2558.
36. Vaisanen,A. et al. (1996) Matrix metalloproteinase-2 (72 kD type IV collagenase) expression occurs in the early stage of human melanocytic tumour progression and may have prognostic value. J. Pathol., 180, 283-289.
37. van den Oord,J.J. et al. (1997) Expression of gelatinase B and the extra-cellular matrix metalloproteinase inducer EMMPRIN in benign and malignant pigment cell lesions of the skin. Am. J. Pathol., 151 665-670.
38. Hofmann,U.B. et al. (2000) Matrix metalloproteinases in human melanoma. J. Invest. Dermatol., 115, 337-344.
39. Zhang,X. et al. (2004) ING4 induces G2/M cell cycle arrest and enhances the chemosensitivity to DNA-damage agents in HepG2 cells. FEBS Lett., 570, 7-12.
40. Ozer,A. et al. (2005) Regulation of HIF by prolyl hydroxylases: recruitment of the candidate tumor suppressor protein ING4. Cell Cycle, 4, 1153-1156.
41. Kath,R. et al. (1993) Prognosis and treatment of disseminated uveal melanoma. Cancer, 72, 2219-2223.
42. Balch,C.M. et al. (2001) Prognostic factors analysis of 17.600 melanoma patients: Validation of the American Joint Committee on Cancer melanoma staging system. J. Clin. Oncol., 19, 3622-3634.